Titel

Merkliste
1 Ergebnisse

Adverse events among patients with cutaneous leishmaniasis ..:

Carla Oliveira-Ribeiro (11473506) ; Maria Inês Fernandes Pimentel (7871222) ; Liliane de Fátima Antonio Oliveira (11473509)...
https://figshare.com/articles/figure/Adverse_events_among_patients_with_cutaneous_leishmaniasis_treated_with_meglumine_antimoniate_according_to_the_three_groups_/16673301. , 2021

Link: https://doi.org/10.1371/journal.pntd.0009734.s006

RT Journal
T1 <Title>Adverse events among patients with cutaneous leishmaniasis treated with meglumine antimoniate according to the three groups</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16673301&Exemplar=1&LAN=DE
				
A1 Carla Oliveira-Ribeiro (11473506)
A1 Maria Inês Fernandes Pimentel (7871222)
A1 Liliane de Fátima Antonio Oliveira (11473509)
A1 Érica de Camargo Ferreira e Vasconcellos (4054375)
A1 Fatima Conceição-Silva (11473512)
A1 Armando de Oliveira Schubach (603149)
A1 Aline Fagundes (4054378)
A1 Cintia Xavier de Mello (10017657)
A1 Eliame Mouta-Confort (4054396)
A1 Luciana de Freitas Campos Miranda (7871216)
A1 Claudia Maria Valete-Rosalino (7871234)
A1 Ana Cristina da Costa Martins (11473515)
A1 Raquel de Vasconcellos Carvalhaes de Oliveira (3203967)
A1 Leonardo Pereira Quintella (10017666)
A1 Marcelo Rosandiski Lyra (10017675)
YR 2021
K1 Medicine
K1 Pharmacology
K1 Biotechnology
K1 Cancer
K1 Infectious Diseases
K1 Virology
K1 rio de janeiro
K1 remains challenging since
K1 good options especially
K1 first therapy option
K1 xlink "> sr
K1 xlink "> treatment
K1 brazil </ p
K1 sr ): intramuscular
K1 xlink "> ar
K1 patients initially treated
K1 5 mg sb
K1 although sr treatment
K1 intramuscular meglumine antimoniate
K1 il showed efficacy
K1 evolution time longer
K1 drugs currently used
K1 treat cutaneous leishmaniasis
K1 3 %
K1 84
K1 5 %
K1 2
K1 9 %
K1 p
K1 6 %
K1 4 %
K1 respectively
K1 ar ): im
K1 meglumine antimoniate
K1 cutaneous leishmaniasis
K1 sr group
K1 il ):
K1 treatment interruption
K1 respectively )
K1 il treatment
K1 2 months
K1 il patients
K1 cutaneous lesions
K1 592 patients
K1 underwent physical
K1 thus contributing
K1 subcutaneous injections
K1 statistical analysis
JF https://figshare.com/articles/figure/Adverse_events_among_patients_with_cutaneous_leishmaniasis_treated_with_meglumine_antimoniate_according_to_the_three_groups_/16673301
LK http://dx.doi.org/https://doi.org/10.1371/journal.pntd.0009734.s006
DO https://doi.org/10.1371/journal.pntd.0009734.s006
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)